Quick Answer
GOLDENWELL BIOTECH, INC. reported Stockholders Equity of -$47.2 thousand for fiscal year 2024.
GOLDENWELL BIOTECH, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$47.2K | -156.1% |
| 2023 | $84.3K | -20.2% |
| 2023 | $105.5K | -25.1% |
| 2023 | $140.9K | -16.1% |
| 2023 | $168.0K | -16.7% |
| 2022 | $201.6K | -14.9% |
| 2022 | $236.9K | -1.9% |
| 2022 | $241.5K | -10.0% |
| 2022 | $268.3K | -11.1% |
| 2021 | $301.7K | -8.9% |
| 2021 | $331.3K | -5.1% |
| 2021 | $349.0K | -6.3% |
| 2021 | $372.6K | +49.9% |
| 2020 | $248.6K | +0.8% |
| 2019 | $246.6K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$94.8K | -592.9% | -9.2% |
| June 30, 2025 | -$86.8K | -2369.7% | -6.4% |
| March 31, 2025 | -$81.6K | -251.9% | -72.8% |
| December 31, 2024 | -$47.2K | -155.8% | -345.5% |
| September 30, 2024 | $19.2K | -81.8% | +402.8% |
| June 30, 2024 | $3.8K | -97.3% | -92.9% |
| March 31, 2024 | $53.7K | -68.0% | -36.6% |
| December 31, 2023 | $84.7K | -58.0% | -19.7% |
- GOLDENWELL BIOTECH, INC. showed a decrease of -156.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2024 period, GOLDENWELL BIOTECH, INC.’s stockholders equity has declined by 119.2% (from $246.6 thousand to -$47.2 thousand).
- The most recent figure is from GOLDENWELL BIOTECH, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: